Top Markets
#1 Verus Coin Verus Coin +45.28%
#2 Status Status +19.17%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#4 GoPlus Security GoPlus Security +16.92%
#5 Wrapped NXM Wrapped NXM +15.51%
#6 Ontology Gas Ontology Gas +11.14%
#7 DMT-NAT DMT-NAT +9.14%
#8 Pons Pons +7.43%
#9 Nesa Nesa +7.39%
#10 Bedrock Bedrock +6.83%
Coin of the day
Verus Coin Verus Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited

Polydex Pharmaceuticals Limited

POLXF
Classifica tra le azioni #33819
Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was... Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was incorporated in 1979 and initially operated as Polydex Chemicals Limited before adopting its current name in March 1984. PPL specializes in the research, development, manufacturing, and global marketing of biotechnology-derived products for the human pharmaceutical sector. Beyond its human health focus, PPL also produces vital pharmaceutical intermediates for the veterinary industry. Its core product line centers on dextran and its various derivatives. Notable examples include iron dextran, a compound administered to newborn pigs to combat anemia, and dextran sulphate, a specialized chemical derivative crucial for biotechnology applications and the broader pharmaceutical sector. Furthermore, the company is actively developing Ushercell, a high molecular weight cellulose sulphate. This innovative product is designed for topical vaginal use, primarily aimed at preventing the transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies. PPL's portfolio further extends to supplying ferric hydroxide and hydrogenated dextran solutions. Products reach the market through a combination of independent distributors, wholesalers, and direct sales channels to various companies.
Prezzo delle azioni
$1.99
Ultima sincronizzazione: 2023-08-07
Capitalizzazione di mercato
$6.82M
Variazione (1 giorno)
0.30%
Variazione (1 anno)
0.00%
Paese
CA
Scambia Polydex Pharmaceuticals Limited (POLXF)

Categoria

Healthcare
Il prezzo POLXF con la capitalizzazione del mercato della B
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
POLXF
$1.99
Capitalizzazione di mercato di Polydex Pharmaceuticals Limited(POLXF)
Capitalizzazione di mercato: $6.82M
A partire dal August 2026, Polydex Pharmaceuticals Limited ha una capitalizzazione di mercato pari a $6.82M. Questo rende Polydex Pharmaceuticals Limited la 33819th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Polydex Pharmaceuticals Limited dal 1981 al 2026
POLXF in paragone con la classifica dei più popolari stocks
Il prezzo per POLXF Attivo B Capitalizzazione del mercato a B Risultati
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,588,258 $6.82M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +79,972,615.54%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,308,049 $6.82M
Apple Inc. Apple Inc.
AAPL
$4.490T +65,863,402.81%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,212,608 $6.82M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +61,057,689.50%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,071,006 $6.82M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +53,927,673.47%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$825,332 $6.82M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +41,557,421.77%